These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17656031)

  • 1. The androgen receptor and prostate cancer: a role for sexual selection and sexual conflict?
    Summers K; Crespi B
    Med Hypotheses; 2008; 70(2):435-43. PubMed ID: 17656031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.
    Alvarado C; Beitel LK; Sircar K; Aprikian A; Trifiro M; Gottlieb B
    Cancer Res; 2005 Sep; 65(18):8514-8. PubMed ID: 16166332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The androgen receptor CAG repeat and prostate cancer risk.
    Clark PE; Irvine RA; Coetzee GA
    Methods Mol Med; 2003; 81():255-66. PubMed ID: 12725125
    [No Abstract]   [Full Text] [Related]  

  • 5. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
    Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
    Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the androgen receptor CAG repeat length significant for prostate cancer?
    Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):985-6. PubMed ID: 12376496
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection.
    Summers K; Crespi B
    Infect Genet Evol; 2008 May; 8(3):297-301. PubMed ID: 18295551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correspondence re: J.L. Stanford et al., Polymorphic receptor in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57: 1194-1198, 1997.
    Yasui T
    Cancer Res; 2000 Jan; 60(2):499. PubMed ID: 10667606
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
    Heemers HV; Regan KM; Dehm SM; Tindall DJ
    Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer.
    Mononen N; Schleutker J
    J Urol; 2009 Apr; 181(4):1541-9. PubMed ID: 19230916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.
    Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M
    Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Androgens and androgen receptor in prostate cancer].
    Miyoshi Y; Kubota Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():489-93. PubMed ID: 16689355
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive selection in the evolution of cancer.
    Crespi BJ; Summers K
    Biol Rev Camb Philos Soc; 2006 Aug; 81(3):407-24. PubMed ID: 16762098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
    Dehm SM; Regan KM; Schmidt LJ; Tindall DJ
    Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralocus sexual conflict.
    van Doorn GS
    Ann N Y Acad Sci; 2009 Jun; 1168():52-71. PubMed ID: 19566703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-apoptotic effect of the androgen receptor in human prostate cancer].
    Shen FY; Li BY
    Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1121-4. PubMed ID: 18284065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual selection and immune function in Drosophila melanogaster.
    McKean KA; Nunney L
    Evolution; 2008 Feb; 62(2):386-400. PubMed ID: 18070086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
    Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
    Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.